Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD

Journal article

Peer reviewed

Lisa K. Stamp, Nicola Dalbeth and David B. Mount

American journal of kidney diseases

24/07/2024

Handle:

https://hdl.handle.net/10523/40997

Metrics

10 Record Views

Record Identifier: 9926556028701891
Title: Yet More Reassurance: Treat-to-Target With Allopurinol or Febuxostat is Safe and Effective in Lowering Serum Urate in People With CKD
Creators: Lisa K. Stamp
Nicola Dalbeth
David B. Mount
Publication Details: American journal of kidney diseases
Academic Unit: Medicine (UOC)
Publisher: Elsevier Inc
Date published ; e-published: 24/07/2024
Language: English
Resource Type ; Subtype: Journal article